-
- ISHIMINE MOMOKO
- Department of Biochemistry, Juntendo University Faculty of Medicine
-
- YOKOMIZO TAKEHIKO
- Department of Biochemistry, Juntendo University Graduate School of Medicine
-
- LEE-OKADA HYEON-CHEOL
- Department of Biochemistry, Juntendo University Graduate School of Medicine
この論文をさがす
抄録
<p> Carboxylesterases (CESs) play important roles in the metabolism of prodrugs containing ester bonds, which are often introduced to improve bioavailability and drug efficacy. CES1 and CES2 are major isozymes encoded by genes in the CES multigene family in humans, and their characteristics such as tissue distribution and substrate specificity have been extensively studied over the past few decades. This mini review briefly summarizes the current knowledge on CES2 focusing on its roles in the metabolism of anticancer prodrugs. We also discuss the regulatory mechanism of CES2 expression, which is often dysregulated in cancer cells. The development of CES2 inhibitors and methods to evaluate CES2 activity in biological samples are also discussed.</p>
収録刊行物
-
- 順天堂醫事雑誌
-
順天堂醫事雑誌 66 (2), 120-124, 2020
順天堂医学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390566775131681792
-
- NII論文ID
- 130007838167
-
- NII書誌ID
- AA1262207X
-
- ISSN
- 21882126
- 21879737
-
- NDL書誌ID
- 030470273
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可